Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,674.52
(
-0.62%
)
US TECH 100
24,010.40
(
-0.51%
)
Dow Jones
46,583.55
(
-0.87%
)
Brent Oil
103.82
(
3.14%
)
Bitcoin
71,899.65
(
-2.76%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 99975

Monday, 08/23/2010 5:32:16 PM

Monday, August 23, 2010 5:32:16 PM

Post# of 257253
LabCorp launches IL-28B gene test:

http://finance.yahoo.com/news/LabCorp-Enhances-HCV-Testing-bw-3886123465.html?x=0&.v=1

IL-28B variants have been found to be correlated to patient response to HCV drugs. Most, if not all, new efficacy trials of HCV drugs will likely have to stratify trial arms according to IL-28B variants.

LabCorp licensed IP from MRK in order to commercialize the IL-28B test (#msg-52716245).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today